Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 205,751,375 papers from all fields of science
Search
Sign In
Create Free Account
Betaseron
Known as:
Beta Seron
, Beta-Seron
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
5 relations
Betaferon
interferon beta-1b 0.3 MG Injection [Betaseron]
Broader (3)
Interferon-beta
Recombinant Interferon Beta
interferon beta-1b
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Cellular self-assembly into 3D microtissues enhances the angiogenic activity and functional neovascularization capacity of human cardiopoietic stem cells
P. Wolint
,
A. Bopp
,
+8 authors
M. Emmert
Angiogenesis
2018
Corpus ID: 51653890
While cell therapy has been proposed as next-generation therapy to treat the diseased heart, current strategies display only…
Expand
Highly Cited
2016
Highly Cited
2016
The 11-year long-term follow-up study from the randomized BENEFIT CIS trial
L. Kappos
,
G. Edan
,
+12 authors
E. Wicklein
Neurology
2016
Corpus ID: 13899215
Objective: To assess outcomes for patients treated with interferon beta-1b immediately after clinically isolated syndrome (CIS…
Expand
Review
2006
Review
2006
Quality Assessment in Multiple Sclerosis Therapy (QUASIMS)
V. Limmroth
,
R. Malessa
,
+13 authors
F. T. I. Group
Journal of Neurology
2006
Corpus ID: 24689971
Interferon beta (IFNβ) preparations are the most frequently prescribed therapies for patients with relapsing multiple sclerosis…
Expand
Highly Cited
2005
Highly Cited
2005
Eight-year immunogenicity and safety of interferon beta-1a-Avonex®treatment in patients with multiple sclerosis
R. Herndon
,
R. Rudick
,
+10 authors
K. Riester
Multiple sclerosis
2005
Corpus ID: 28799526
An open-label extension study of the phase III trial of intramuscular interferon beta-1a (IFNβ-1a-Avonex) was conducted to…
Expand
Review
2001
Review
2001
A prospective, open-label treatment trial to compare the effect of IFNβ-1a (Avonex®), IFNβ-1b (Betaseron®), and glatiramer acetate (Copaxone®) on the relapse rate in relapsing-remitting multiple…
O. Khan
,
A. Tselis
,
J. Kamholz
,
J. Garbern
,
R. Lewis
,
R. Lisak
Multiple sclerosis
2001
Corpus ID: 25969009
We previously reported results of a 12 month prospective, non-randomized, open-label treatment trial of immunomodulatory therapy…
Expand
Review
2001
Review
2001
A prospective, open-label treatment trial to compare the effect of IFN beta-1a (Avonex), IFNbeta-1b (Betaseron), and glatiramer acetate (Copaxone) on the relapse rate in relapsing-remitting multiple…
O. Khan
,
A. Tselis
,
J. Kamholz
,
J. Garbern
,
R. Lewis
,
R. Lisak
European journal of neurology
2001
Corpus ID: 46299650
A prospective, non-randomized, open-label treatment trial was performed in patients with relapsing-remitting multiple sclerosis…
Expand
Highly Cited
1998
Highly Cited
1998
Comparative study of the pharmacodynamic and pharmacologic effects of Betaseron and AVONEX.
G. Williams
,
P. Witt
Journal of interferon & cytokine research : the…
1998
Corpus ID: 45613220
The aim of this 1 week study was to compare the biologic effects induced by Betaseron and AVONEX using their approved dose, route…
Expand
1997
1997
Anticytokine antibodies in beta interferon-treated MS patients and the need for testing: Plight of the practicing neurologist
A. Pachner
Neurology
1997
Corpus ID: 39399630
The recently reported decrease in beta interferon (IFNβ) efficacy induced by anti-IFNβ antibodies1 has prompted Berlex…
Expand
1996
1996
Detection of altered T helper 1 and T helper 2 cytokine production by peripheral blood mononuclear cells in patients with multiple sclerosis utilizing intracellular cytokine detection by flow…
B. Crucian
,
P. Dunne
,
H. Friedman
,
R. Ragsdale
,
S. Pross
,
R. Widen
Clinical and diagnostic laboratory immunology
1996
Corpus ID: 40394757
Production of T helper 1 and T helper 2 cytokines was investigated in peripheral blood mononuclear cells (PBMCs) from multiple…
Expand
1995
1995
The use of Zwittergent 3-14 in the purification of recombinant human interferon-beta Ser17 (Betaseron).
D. Russell-Harde
,
M. Knauf
,
E. Croze
Journal of interferon & cytokine research : the…
1995
Corpus ID: 28266401
A new method for purifying human interferon-beta SER17 from E. coli-derived inclusion bodies has been developed. This procedure…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
,
Terms of Service
, and
Dataset License
ACCEPT & CONTINUE